Navigation Links
NineSigma's Non-Profit Guide to The Grand Challenge Empowers Non-Profit Leaders to Achieve their Mission while Amplifying Awareness of their Cause
Date:9/19/2013

CLEVELAND, Sept. 19, 2013 /PRNewswire/ -- NineSigma, Inc., of Cleveland, the leading innovation partner to organizations worldwide, today published The Foundation and Non-Profit Leader's Guide to the Grand Challenge. Philanthropists, endowment managers, non-profit executives and boards of trustees want to be associated with success as much as CEOs of large companies. But the challenges they face are often more complex and cannot be solved with traditional corporate best practices alone.

This new guide addresses issues unique to non-profits in their quest to solve the world's biggest challenges, both by rallying internal resources around a shared vision, and collaborating with the world's leading experts and scientists. Through a Grand Challenge, a non-profit organization can realize bigger ambitions than other giving-back programs can deliver, while dramatically heightening visibility of the causes that drive them.

The origin of Grand Challenges began with early programs like offering rewards and recognition to those who could solve long-standing issues like mapping longitudinal locations before modern mapping technologies existed. These programs evolved into contemporary challenges like reversing global warming, ending malnutrition and curing pandemic diseases like HIV/AIDS. These challenges capture the world's imagination and have the power to unify the global innovator community. 

Andy Zynga, CEO of NineSigma says, "We are experts in facilitating the most high-value partnerships and collaborations in the world – and often they're not obvious matches. As we've seen in creating and executing a myriad of Grand Challenges for non-profits, there are a world of potential partners and solution providers who can collaborate to create a new level of global impact."

A successful Grand Challenge depends on several factors such as articulating a major issue, engaging the right technical audiences, and keeping the program top of mind for the general public. The guide maps out all key considerations, including:

  • Challenge definition
  • Identifying the right Grand Challenge
  • Program design
  • Interactions with technical communities
  • Establishing and communicating the timeline
  • Prize strategy
  • When to partner
  • How to market a Grand Challenge

NineSigma has run Grand Challenges for foundations, non-profits and corporations alike. Recently these have included the first phase of the CCEMC Grand Challenge for the Climate Change and Emissions Management (CCEMC) Corporation to convert carbon from a liability to an asset, the GE NFL Head Health Challenge to diagnose mild traumatic brain injury, and GE for a new 3D Printing Production Quest.  "The response to the first round of the CCEMC Grand Challenge surpassed our expectations with 344 submissions from 37 countries," says CCEMC Chair Eric Newell. "We are pleased to be leveraging NineSigma's expertise and are optimistic that this open innovation competition will foster multiple technologies that can be deployed in Alberta to convert carbon into useful products and complement other greenhouse gas reduction strategies currently in development in the province."

NineSigma has also crafted and executed Grand Challenges on behalf of the International AIDS Vaccine Initiative (IAVI) and LAUNCH, a joint initiative of NASA, the US Agency for International Development (USAID), the Department of State, and NIKE. These initiatives, along with other prize-based challenges are hosted on NineSigma's social media and open innovation platform, NineSights.

The Foundation and Non-Profit Leader's Guide to The Grand Challenge is available for download free at http://www.ninesigma.com/foundation-grand-challenge-guide.

About NineSigma

NineSigma connects organizations with external innovation resources to accelerate innovation in private, public and social sectors. The company provides open innovation services to organizations worldwide, including Mondelez, Philips, Siemens, and Unilever, to solve immediate challenges, integrate new knowledge, fill product pipelines, and stay ahead of the competition. Named to the 2012 Inc. 5000 list of fastest-growing private U.S. companies, NineSigma's proprietary process has produced billions of dollars in value for its clients. NineSigma has the largest open global network of solution providers and an extensive database of existing solutions spanning numerous industries and technical disciplines. NineSigma's online innovation community, NineSights®, is the world's first open innovation social media destination, connecting innovators of all sizes with resources and relationships to drive growth. Learn more at www.ninesigma.com and www.ninesights.com

Media Contact: 
Jackie Lucas, Warner Communications – jackie@warnerpr.com, (978) 255-1159 


'/>"/>
SOURCE NineSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. National Non-Profit Awards Audio Conferencing to SoundConnect
2. New Reporting Guidelines For Case Reports Presented At The Congress On Peer Review And Biomedical Publication And Published In Seven Medical Journals
3. Broad-scale genome tinkering with help of an RNA guide
4. Trade Show Displays Buyer's Guide Helps Exhibitors Maximize Their Booth Space
5. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
6. A Simple Guide to De-Risking Before Full Prescribing Information, New Life Science Webinar Hosted by Xtalks
7. New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests
8. FDA/PhUSE Collaboration: Study Data Reviewer’s Guide Work Package v1.1 Available
9. How to Kill Fleas Guide Published by My Cleaning Products Along with Launch of Its Pesticide Exempt Flea Control Product
10. My Cleaning Products Gives Out 20% Bed Bug Bully Discount, Publishes New Bed Bug Treatment Guide
11. Guide How to Kill Spiders Released by My Cleaning Products Together with Its Non-Pesticide Spider Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
(Date:12/8/2016)... South Korea , Dec. 8, 2016 ... a $21 billion KRW (US $18.9M) Series A financing. ... Kolon Investment, G.N. Tech Venture and SNU Bio Angel. ... Eutilex to 30.5 billion KRW (US $27.7M) since its ... help Eutilex to bolster the development and commercialization of ...
(Date:12/8/2016)... DIEGO , Dec. 8, 2016   ... a leading commercial provider of clinically actionable liquid ... patients, announces that clinical data featuring its Target ... to tissue biopsy for the detection of actionable ... results from research sponsored by Sara Cannon Research ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
(Date:12/6/2016)... WARSAW, Ind. , Dec. 6, 2016  Zimmer Biomet ... that it has priced an offering of €500.0 million principal ... €500.0 million principal amount of its 2.425% senior unsecured notes ... is expected to occur on December 13, 2016, subject to the ... on an annual basis. ...
Breaking Biology News(10 mins):